Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related functional changes

INTRODUCTION: The role of gut microbiome dysbiosis in the pathogenesis of psoriasis has gained increasing attention in recent years. Secukinumab, targeting interleukin (IL)-17, has a promising efficacy in psoriasis treatment. However, it remains unclear the gut microbiota alteration and related func...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xueshan, Yan, Cong, Kong, Shuzhen, Che, Delu, Peng, Bin, Zhu, Longfei, Geng, Songmei, Guo, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445136/
https://www.ncbi.nlm.nih.gov/pubmed/37621397
http://dx.doi.org/10.3389/fmicb.2023.1227309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445136/
https://www.ncbi.nlm.nih.gov/pubmed/37621397
http://dx.doi.org/10.3389/fmicb.2023.1227309

Ejemplares similares